Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Tech Press.
Press releases published on September 29, 2025
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
Designed to unlock potential value by creating two independent, publicly traded companies with different business objectives and opportunities Upon completion, the royalty management company will manage royalties and milestone payments from financial …
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will host a virtual investor event on ANB033, its CD122 …
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting Late Breaking Abstract titled EFFICACY AND SAFETY OF OBEFAZIMOD IN PATIENTS …
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
Initial $100 million term loan to propel market share growth in the U.S. SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their …
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass. and BOULDER, Colo., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that on September 25, 2025, …
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
LEXINGTON, Mass. and AMSTERDAM, Sept. 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of its previously …
ImmuCell Announces Selection of its Next President and CEO
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Progress Software Announces Third Quarter 2025 Financial Results
Annualized Recurring Revenue ("ARR") of $849 million Grew 47% year-over-year Revenue of $250 million Grew 40% year-over-year Raises Full Year Guidance for Revenue, Earnings Per Share, and Cash Flow BURLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- …
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
Placebo-subtracted mean weight loss up to 14.1% after 28 weeks with no plateau Potential for best-in-class tolerability with minimal diarrhea signal, 13% nausea, and 11% vomiting High study and treatment retention in both VESPER-1 and VESPER-3 trials Data …
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Keith …
Kura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)
– KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated and full approval – – KOMET-017-NIC trial of venetoclax / azacitidine combination will assess CR …
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on immuno-dermatology, today announced that it will report third quarter 2025 financial results …
ZIWO Launches Innovative Voice AI Agent, Revolutionizing Customer Experience in the MENA Region
ZIWO Voice Agent automates customer service calls with a new AI-powered assistant. The solution supports natural conversations in Arabic, English, and French, locally hosted in the MENA region, ensuring data security and compliance. The new feature will be …
Persephone Biosciences Co-Sponsors Event With Clean Label Project At Annual American Academy Of Pediatrics Conference
DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Persephone Biosciences, a pioneering biotech company focused on unlocking the potential of the microbiome to impact human health, today co-sponsored Clean Label Project’s ‘Coffee …
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure transfer of more than $10 trillion to date SARASOTA, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a …
TechSmith Announces Inaugural TechSmith Unlocked Virtual Conference
EAST LANSING, Mich., Sept. 29, 2025 (GLOBE NEWSWIRE) -- TechSmith Corporation, an industry leader in visual communication, today announced its inaugural TechSmith Unlocked virtual conference, a one-day event designed to showcase the company’s tech …
OxyCon 2025 to Address the Future of Web Access
Last call to register for a free online spot to follow the conference live VILNIUS, Lithuania, September 29, 2025 — The open internet as we know it is rapidly changing, stress speakers of the foremost web scraping conference OxyCon. The free-to-register …
SOTI SYNC 25 Kicks Off in Montreal, Canada: Where Leaders, Legends & Technology Converge
MONTREAL, Canada, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SOTI SYNC 25 has kicked off in Montreal, Canada, marking the start of four exciting days of hands-on training, insightful keynotes and inspiring customer success stories. Hosted by SOTI, a global leader …
The Bond Buyer Debuts Legal Intelligence and Welcomes Jeff Lipton as Market Intelligence Analyst
New York, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Arizent, a leading provider of market intelligence and business information, is pleased to announce that Jeff Lipton has joined as Market Intelligence Analyst, Municipals. In this role, Lipton will support The …